Prospective, controlled, randomized trial investigating changes in levels of various cytokines post intravitreal injection by triamcinolone or bevacizumab in treatment of branch retinal vein occlusion (BRVO)

Trial Profile

Prospective, controlled, randomized trial investigating changes in levels of various cytokines post intravitreal injection by triamcinolone or bevacizumab in treatment of branch retinal vein occlusion (BRVO)

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Triamcinolone (Primary)
  • Indications Retinal vein occlusion
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top